Abdullah Tarık Aslan

486 total citations
13 papers, 143 citations indexed

About

Abdullah Tarık Aslan is a scholar working on Molecular Medicine, Pharmacology and Epidemiology. According to data from OpenAlex, Abdullah Tarık Aslan has authored 13 papers receiving a total of 143 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Medicine, 6 papers in Pharmacology and 6 papers in Epidemiology. Recurrent topics in Abdullah Tarık Aslan's work include Antibiotic Resistance in Bacteria (7 papers), Antibiotic Use and Resistance (6 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Abdullah Tarık Aslan is often cited by papers focused on Antibiotic Resistance in Bacteria (7 papers), Antibiotic Use and Resistance (6 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Abdullah Tarık Aslan collaborates with scholars based in Australia, Türkiye and Singapore. Abdullah Tarık Aslan's co-authors include Murat Akova, David L. Paterson, Patrick N. A. Harris, Burcu Isler, Fekade B. Sime, Juan Pablo Horcajada, Jason A. Roberts, Robert Fowler, Małgorzata Mikulska and Nick Daneman and has published in prestigious journals such as Intensive Care Medicine, Clinical Microbiology and Infection and International Journal of Antimicrobial Agents.

In The Last Decade

Abdullah Tarık Aslan

13 papers receiving 138 citations

Peers

Abdullah Tarık Aslan

AMB

PHARM

EPIDE

Rosaria Lionello Italy

Marianna Rossi Italy

Juan Carlos Ramos Ramos Spain

Galina Reshedko Russia

Mary Banoub United States

Carlos Bergallo Argentina

R. Andini Italy

Şirin Menekşe Türkiye

Lorenzo Volpicelli Italy

Evangelia Neou Greece

Rosaria Lionello Italy

Abdullah Tarık Aslan

62 ×0.7

34 ×0.7

AMB

43 ×0.9

PHARM

55 ×1.3

EPIDE

12 ×0.4

Citations per year, relative to Abdullah Tarık Aslan Abdullah Tarık Aslan (= 1×) peers Rosaria Lionello

Countries citing papers authored by Abdullah Tarık Aslan

Since Specialization

Citations

This map shows the geographic impact of Abdullah Tarık Aslan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdullah Tarık Aslan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdullah Tarık Aslan more than expected).

Fields of papers citing papers by Abdullah Tarık Aslan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdullah Tarık Aslan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdullah Tarık Aslan. The network helps show where Abdullah Tarık Aslan may publish in the future.

Co-authorship network of co-authors of Abdullah Tarık Aslan

This figure shows the co-authorship network connecting the top 25 collaborators of Abdullah Tarık Aslan. A scholar is included among the top collaborators of Abdullah Tarık Aslan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdullah Tarık Aslan. Abdullah Tarık Aslan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Tabah, Alexis, Jan J. De Waele, Abdullah Tarık Aslan, et al.. (2025). Source control in bloodstream infections in patients with sepsis, septic shock, or requiring ICU admission: a scoping review with recommendations for standardizing research. Intensive Care Medicine. 51(8). 1462–1475. 1 indexed citations

Aslan, Abdullah Tarık, Neşe Saltoğlu, Mesut Yılmaz, et al.. (2025). Comparison of ceftazidime-avibactam with other appropriate antimicrobial therapy for the treatment of OXA-48- or KPC-producing Enterobacterales infections in Türkiye: A multi-centre retrospective matched-cohort study. International Journal of Antimicrobial Agents. 67(1). 107650–107650. 1 indexed citations

Aslan, Abdullah Tarık & David L. Paterson. (2024). Epidemiology and clinical significance of carbapenemases in Australia: a narrative review. Internal Medicine Journal. 54(4). 535–544. 5 indexed citations

Aslan, Abdullah Tarık, et al.. (2024). Prevention and treatment of bacterial infections in patients with haematological cancers and haematopoietic stem cell transplantation: headways and shortcomings. Clinical Microbiology and Infection. 31(1). 24–28. 5 indexed citations

Aslan, Abdullah Tarık, et al.. (2023). The Opportunities and Challenges for Artificial Intelligence to Improve Sepsis Outcomes in the Paediatric Intensive Care Unit. Current Infectious Disease Reports. 25(11). 243–253. 8 indexed citations

Aslan, Abdullah Tarık, et al.. (2023). Scoping review of risk-scoring tools for early prediction of bloodstream infections caused by carbapenem-resistant Enterobacterales: do we really have a reliable risk-scoring tool?. JAC-Antimicrobial Resistance. 6(1). dlae032–dlae032. 2 indexed citations

Roberts, Jason A., et al.. (2023). The global epidemiology of ventilator-associated pneumonia caused by multi-drug resistant Pseudomonas aeruginosa: A systematic review and meta-analysis. International Journal of Infectious Diseases. 139. 78–85. 20 indexed citations

Isler, Burcu, Abdullah Tarık Aslan, David L. Paterson, et al.. (2023). Duration of antibiotic treatment and timing of oral switching for bloodstream infections: a survey on the practices of infectious diseases and intensive care physicians. International Journal of Antimicrobial Agents. 61(6). 106802–106802. 4 indexed citations

Aslan, Abdullah Tarık, et al.. (2023). In vitro, in vivo and clinical studies comparing the efficacy of ceftazidime-avibactam monotherapy with ceftazidime-avibactam-containing combination regimens against carbapenem-resistant Enterobacterales and multidrug-resistant Pseudomonas aeruginosa isolates or infections: a scoping review. Frontiers in Medicine. 10. 1249030–1249030. 13 indexed citations

10.

Aslan, Abdullah Tarık, Murat Akova, & David L. Paterson. (2022). Next-Generation Polymyxin Class of Antibiotics: A Ray of Hope Illuminating a Dark Road. Antibiotics. 11(12). 1711–1711. 22 indexed citations

11.

Isler, Burcu, Abdullah Tarık Aslan, Murat Akova, Patrick N. A. Harris, & David L. Paterson. (2022). Treatment strategies for OXA-48-like and NDM producing Klebsiella pneumoniae infections. Expert Review of Anti-infective Therapy. 20(11). 1389–1400. 35 indexed citations

12.

Aslan, Abdullah Tarık & Murat Akova. (2021). Current status of therapeutic alternatives for COVID-19: A narrative review. Infezioni in Medicina. 29(3). 312–327. 9 indexed citations

13.

Aslan, Abdullah Tarık & Murat Akova. (2019). Extended spectrum β-lactamase producing enterobacteriaceae: carbapenem sparing options. Expert Review of Anti-infective Therapy. 17(12). 969–981. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact